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Ionotropic glutamate receptors, such as NMDA, AMPA and kainate receptors, are ligand-gated ion channels that mediate much
of the excitatory neurotransmission in the brain. Not only do these receptors bind glutamate, but they are also regulated by and
facilitate the postsynaptic uptake of the trace metal zinc. This paper discusses the role of the excitotoxic inﬂux and accumulation
of zinc, the mechanisms responsible for its cytotoxicity, and a number of disorders of the central nervous system that have been
linked to these neuronal ion channels and zinc toxicity including ischemic brain injury, traumatic brain injury, and epilepsy.
1.Introduction
Although zinc is clearly an essential trace element that is
required for the function of hundreds of enzymes and DNA-
binding transcription factors, excessive zinc has long been
implicated in processes leading to cellular damage. In the
central nervous system large amounts of zinc can enter
postsynaptic neurons through a variety of ion channels
including glutamate receptors and voltage-gated calcium
channels. This paper will ﬁrst discuss the cellular pools
of zinc, the mechanisms that appear to be responsible
for the accumulation of neuronal zinc, and then outline
the current hypotheses about how excess zinc exploits ion
channels and other mechanisms to produce neurotoxicity in
the hippocampus, amygdala, and cortex under pathological
conditions. With these mechanisms in mind we will then
discuss relevant clinical situations such as traumatic brain
injury, ischemic injury (stroke), and epilepsy, where excess
zinc accumulation can lead to neurodegeneration.
2.NeurotoxicZinc:CellularSources
andRoutes of Entry
2.1. Sources of Neurotoxic Zinc. While a majority of zinc
in the central nervous system (CNS) is tightly bound to
zinc-dependent enzymes and other proteins, approximately
10% is “free” or “chelatable” zinc which is not associated
with proteins or aminoacid ligands. Under pathological
conditions, free zinc appears to participate in the neurotoxic
accumulation of zinc in neurons. In normal neurons, free
zinc is predominately localized to the presynaptic vesicles of
glutamatergic neurons [1, 2]. Free zinc has also been colo-
calized to GABA and glycine containing murine neurons [3].
Regions rich in vesicular free zinc include the mossy ﬁbers
of the hippocampus, the amygdala, and the olfactory bulb.
“Zincergic” neurons are also abundant in the cortex [4].
In addition to the large pool of vesicular zinc, there
is clear evidence for additional intracellular pools of zinc
that can be liberated to form free zinc. The strongest case
for the presence of nonvesicular pools of free zinc comes
from a report showing that free zinc accumulates after
seizure activity in animals that lack vesicular zinc [5]. This
work measured free zinc accumulation in the hippocampal
neurons of ZnT3-null mice that lack the ability to pump zinc
into synaptic vesicles. While this work did not deﬁnitively
determine the source of the non-vesicular free zinc, the
surprising ﬁnding that these animals exhibited accumulation
of free zinc in damaged neurons after kainate-induced
seizures began the hunt for alternative pools of free zinc
that may participate in neurotoxicity. Subsequently, others2 Journal of Toxicology
have identiﬁed a mitochondrial pool of zinc that can be both
inﬂuenced by the amount of intracellular zinc as well as
contribute to it [6]. There is also now evidence that protein
bound zinc can be mobilized to form a free zinc pool under
oxidative conditions [7].
2.2. Routes of Neurotoxic Zinc Entry. Upon neuronal exci-
tation, vesicular zinc is released into the synaptic cleft.
Under normal conditions, the primary function of the zinc
from synaptic vesicles appears to be the modulation of
both ionotropic and metabotropic post-synaptic receptors
through zinc-speciﬁc allosteric binding sites. For example,
zinc inhibits GABAA receptors, reducing their inhibitory
action [8, 9]. The eﬀect of zinc on excitatory glutamate
receptors is complex. Not only can zinc act as an inhibitory
neuromodulator of glutamate release [10], but it was initially
thought to inhibit activity of NMDA glutamate receptors
[9, 11]. However, there are reports of biphasic and cell type-
speciﬁc zinc regulation of both NMDA and AMPA/kainate
glutamate receptors [12–15]. Additionally, zinc can poten-
tiate glycine-mediated currents [16] and regulate voltage-
gated calcium channels [17]a sw e l la sp o t a s s i u m ,s o d i u m ,
and chloride channels [18].
However, under pathological conditions, excess free zinc
is released from synaptic and other free zinc pools. As
excess zinc ﬂoods the synaptic cleft, it exploits a variety
of receptors and channels to gain entry into post-synaptic
n e u r o n s .T h e r ea p p e a rt ob ea tl e a s tf o u rd i ﬀerent routes
of entry. First, AMPA/kainate glutamate receptors have
been identiﬁed as the primary route of entry for zinc
into post-synaptic neurons [19]. Zinc also exploits NMDA
glutamate receptors to gain entry into neurons. Both of these
glutamate binding receptors transport calcium as well as
zinc into post-synaptic neurons. The third route of entry
for toxic levels of zinc is voltage-gated calcium channels
[19–21]. Finally, excess zinc appears to enter neurons via
a transporter-mediated exchange with intracellular sodium.
While the presence of a putative Na+/Zn+2 exchanger has
been hypothesized, it is also probable that when excess zinc
is released from presynaptic neurons, it can replace calcium
and gain entry into neurons via Na+/Ca+2 exchange proteins
[20].
3. Mechanismsof ZincNeurotoxicity
Damage to the CNS induced by seizure, trauma, or ischemia
can all result in the accumulation of zinc from vesicular
and non-vesicular zinc pools. While it is clear that the
excess zinc that is detected in these and other pathological
conditions is neurotoxic, there is considerable debate about
the cause of the toxicity. There are three main hypotheses
that are currently being explored, namely, that excess zinc:
causes excitotoxicity, induces oxidative stress, and impairs
the generation of cellular energy. In fact, as the next several
sections will show, there is evidence for each of these
mechanisms, suggesting that they are not mutually exclusive,
and that all three actions of zinc may be acting synergistically
to cause neuronal damage and death.
3.1. Excitotoxicity. The inﬂux of excess zinc into neurons has
been shown to result in excitotoxic damage to post-synaptic
neurons. This is in part mediated by the action of zinc on
glutamate receptors and other ion channels. For example,
when large amounts of glutamate and zinc are released
together from pre-synaptic neurons, there is an acute block
of NMDA glutamate receptors as zinc binds to allosteric sites
on these ion channels. However, this acute downregulation
is followed by a Src family kinase-mediated upregulation
of NMDA receptor activity that appears to participate in
neuronal damage and cytotoxicity [12].
3.2. Oxidative Stress. Excess zinc has been implicated in the
generation of oxidative stress by free radicals and reactive
oxygenspecies(ROS)leadingtoneuronaldamageanddeath.
In fact, it was recently hypothesized that the combination of
age-related oxidation and resulting zinc accumulation could
actsynergisticallytopromoteaging-relatedneuronaldamage
and neurodegeneration [22]. In support of this hypothesis,
treatment of mouse cortical neuron cultures with 30–35μM
zinc for 24 hours triggered processes eventually leading to
neuronal, but not glial, death [23] that was accompanied by
membrane lipid peroxidation. Interestingly, while the neu-
rotrophins NT-3, NT-4/5 and brain-derived neurotrophic
factor (BDNF) were unable to prevent the zinc-induced
neurotoxicity, the water soluble form of vitamin E, trolox,
almost completely prevented the neuronal death associated
with excess zinc in these cultures [23, 24]. Zinc toxicity,
both as a result of zinc applied directly to neuronal cultures
and after kainate application, was also prevented by the
additionofglutathione[25].Together,thesedatasuggestthat
much of the neuronal damage was the result of free radical
generation.
It should be noted that the neuronal death was accompa-
nied by classical features of apoptosis including internucle-
osomal DNA fragmentation, as well as other characteristics
commonly associated with necrosis such as swelling of intra-
cellular organelles [23, 24]. While the authors of this early
report suggest that zinc may trigger necrosis, subsequent
work has shown that neuronal apoptosis is complex and
frequently cannot be categorized into strictly apoptosis or
necrosis, but is probably best described as a continuum, with
characteristics that include those classically associated with
both apoptosis and necrosis [26].
Clearly the next question is how excess zinc leads to
the production of ROS. Early evidence suggested a role for
zinc in the regulation of neuronal protein kinase C (PKC)
[27]. While this initial report linked the zinc-regulation of
PKC to oxidative damage, it was subsequent work that led
to the elucidation of the mechanism responsible for the
PKC-dependent generation of ROS in zinc-loaded neurons.
Namely, it appears that zinc-stimulated PKC enhances
the expression of the enzyme NADPH oxidase. Zinc also
facilitates the translocation of the NADPH oxidase subunits
p47PHOX and p67PHOX to the neuronal membrane, where
they participate in the generation of ROS [28]. Zinc-
stimulatedNADPHoxidasemayalsostimulatetheactivation
of poly (SDP-ribose) polymerase (PARP), which can triggerJournal of Toxicology 3
apoptotic processes [29]. While it is clear that these may not
be the only mechanisms responsible for the generation of
ROSin zinc-loaded cells, theworkdoes shed light on the role
of oxidation in zinc toxicity.
3.3. Impaired Energy Production. While early work showed
that nanomolar concentrations of zinc were capable of
signiﬁcantlyinhibitingtheglycolyticenzymeglyceraldehyde-
3-phosphate dehydrogenase (GAPDH), our current under-
standing of the role of zinc in neuronal glycolysis is that
excesszincrapidlyreducescellularlevelsofnicotinamideade-
nine dinucleotide (NAD+)[ 30–32]. This reduction in NAD+
is not only responsible for the reduced activity of GAPDH
andthesubsequentaccumulationofdihydroxyacetonephos-
phate (DHAP) and fructose 1,6 bisphosphate, but also leads
to a reduction in ATP levels and subsequent neuronal
death [30]. Reductions in NAD+ w o u l db ee x p e c t e dt o
reduce cellular ATP production not only because it inhibits
the activity of glycolytic enzymes, but also because of the
resultinginhibitionofmitochondrialrespiratoryenzymes.In
fact, several studies have reported reductions in the NAD+
dependent enzymes alpha-ketoglutarate dehydrogenase and
isocitrate dehydrogenase as well as other mitochondrial
enzymes including succinate dehydrogenase and aconitase
[33, 34].
Other mechanisms leading to zinc-induced mitochon-
drial dysfunction including the RAS/ERK/MAPK signaling
pathway [35], where ERK 1/2 is likely activated via zinc
induction of the immediate early gene erg-1 [36], and
MAPK signaling leads to mitochondrial hyperpolarization
[35]. Furthermore, mitochondrial traﬃcking, which has
been hypothesized to play a role in neurodegeneration, is
impairedbyexcesszinc,potentiallybyaphosphatidylinositol
3-kinase-mediated mechanism [37]. Not only can zinc act
as an independent modulator of mitochondrial function,
it also appears to act synergistically with other agents
such as kainate to induce mitochondrial dysfunction and
neuronal death [38, 39]. This appears to be facilitated by
the mitochondrial uptake of zinc, followed by the release of
proapoptotic mitochondrial proteins such as cytochrome c
and the apoptosis induction factor, AIF [40].
4.ZincToxicityinNeurological
Diseaseand Disorders
The proposed mechanisms associated with zinc neurotoxic-
i t yh a v eb e e ni m p l i c a t e di nal a r g en u m b e ro fn e u r o d e g e n -
erative disorders including amyolateral sclerosis, Alzheimer’s
disease, and Parkinson’s disease. The strongest links, how-
ever, between the excess zinc release and uptake via ion
channels have been observed in models of ischemic brain
injury, traumatic brain injury, and seizure disorders.
4.1.ZincandIschemicBrainInjury. Althoughitsroleisunder
active investigation, zinc dysregulation has been implicated
in mechanisms leading to neuronal damage and death after
ischemic brain injury. Tønder et al. ﬁrst suggested a role of
zinc toxicity in the neuronal death associated with global
ischemia. In this early report, when adult rats were subjected
to global brain ischemia there was a decrease in free zinc
associated with mossy ﬁber layers of the hippocampus and
an increase in the dentate hilar region of degenerating
neurons [41].In another model of stroke, transient forebrain
ischemia, zinc left pre-synaptic terminals and accumulated
in post-synaptic neurons. This translocation was associated
with degeneration of neurons in the hippocampus, cerebral
cortex, thalamus, striatum, and amygdala. An intracerebral
injection with the membrane impermeant zinc chelator Ca-
EDTA prior to ischemia was neuroprotective and signiﬁ-
cantly decreased neuronal death [42]. Administration of Ca-
EDTA 30min prior to mild focal ischemia reduced infarct
size 3 days after injury. However, the infarct reduction was
lost when rats were euthanized 14 days later, even when Ca-
EDTA was continuously perfused [43].
Aspirinisananti-inﬂammatorydrugcommonlyusedfor
secondary prevention after stroke and is protective against
NMDA-induced and zinc-induced neurotoxicity. The appli-
cation of 3–10mM aspirin to cortical neurons exposed to
300μMzincfor30minpreventedneuronaldegenerationbut
not oxidative stress or apoptosis. It was shown that aspirin
preventedzincentryintoneuronsbyinhibitingvoltage-gated
calcium channels, which is a main route for zinc entry into
neurons [44].
4.2. Zinc and Traumatic Brain Injury. There is also a rela-
tionship between accumulation of free zinc and neuronal
degeneration following traumatic brain injury. In one study,
adult rats and neonatal pups were given a unilateral cortical
stab wound. Four weeks following injury, adult rats, but
not neonatal pups, showed increased TSQ staining of free
zinc in and around the site of injury, suggesting that
the accumulation of free zinc is responsible for neuronal
death [45]. A TBI model of mechanical cortical trauma
in rats resulted in loss of zinc from pre-synaptic vesicles
and movement into post-synaptic neurons accompanied by
neuronal death in the hilus, dentate gyrus, and CA1 regions
of the hippocampus [46]. It was further demonstrated that
ratsgivenamildormoderateTBIbyaﬂuidpercussioninjury
showed that injured neurons stained with Fluoro-Jade in the
hippocampalregionsofCA1,CA3,anddentategyrus4hours
and 24 hours after injury contained high levels of free zinc
as detected by the zinc indicator Newport Green. This is
an important ﬁnding because it suggests that an increase in
free zinc after brain injury is neurotoxic and causes neuronal
death in the hippocampus [47].
Additional evidence that high levels of free zinc are
involved in neuronal degeneration after brain injury comes
fromexperimentsdemonstratingthatinjectionsoftheextra-
cellularzincchelatorCa-EDTA beforeTBIprovidedaneuro-
protective eﬀect by reducing cell death in the hippocampus
[46]. Pretreatment with Ca-EDTA before a TBI-induced
modelofﬂuidpercussioninjuryreducedapoptoticcelldeath
measured by TUNEL labeling while also upregulating the
expression of neuroprotective genes [48]. However, rats that
were given a TBI and Ca-EDTA treatment did not have
improved learning and memory performance in the Morris4 Journal of Toxicology
WaterMazetesttwoweeksafterTBI.Althoughzincchelation
provides short-term histological beneﬁts, it does not appear
to improve long-term functional outcomes [49].
Interestingly, recent evidence has suggested that the
source of the zinc that accumulates after TBI in mice is
not exclusively vesicular and has led researcher to question
some of the previous assumptions about the role of zinc in
brain injury. ZnT3-knockout mice that lack vesicular zinc
showed an increase in injured neurons and apoptotic cells
compared to wild-type (WT) control mice 24 hours after
injury. After chemical blocking of vesicular zinc in post-TBI
ZnT3 KO and WT mice, damage was unchanged in ZnT3
KO mice, while the numbers of apoptotic cells increased in
WT mice with levels comparable to ZnT3 KO mice. This
new evidence suggests that free vesicular zinc may actually
play a neuroprotective role after TBI [50]. Clearly more work
will be needed to understand the role of zinc, glutamate
receptors, calcium channels, and other mechanisms after
traumatic brain injury. In light of these new data it is
interesting to note that administration of zinc appears to
have a positive eﬀect on outcomes after TBI. In one clinical
trial, zinc supplementation improved neurological scores
following TBI [51]. More recent work in a rat model of TBI
showed that zinc can provide behavioral resiliency to TBI
whengiven4weekspriortoinjuryandresultinginimproved
cognition and reduced depression- and anxiety-like behav-
iors [52]. The mechanisms responsible for the robust eﬀect
of zinc in this model are currently under investigation
ZnT3.
4.3. Zinc and Epilepsy. Zinc dysregulation and homeostasis
has been suggested to play a role in the development of
seizures. In an epilepsy mouse model, zinc levels were signif-
icantly lower in the hippocampus when compared to control
mouse strains [53]. There is also evidence that zinc translo-
cates from pre-synaptic boutons into post-synaptic neu-
rons, possibly causing neuronal degeneration after seizure
[54].
As discussed previously, synaptic zinc acts as a neuro-
modulator and regulates the activity of a variety of post-
synaptic receptors including NMDA, GABAA,a n dA M P A
receptors, which then determine neuronal excitability [55].
As a result of its ability to act as a neuromodulator, zinc has
been implicated as a proconvulsant [56] and anticonvulsant
[57]. Studies that support the proconvulsant theory showed
that seizures were induced by an injection of zinc sulfate
in rabbits [56]. It has also been shown that zinc chloride
enhances kainate neurotoxicity in the hippocampus. Inter-
estingly, CNQX, an NMDA antagonist, helped to prevent
neuronal damage [58]. During kindling-induced seizures in
whichastimuluswasappliedfortentimesadayfortwodays,
and the zinc chelator diethildythiocarbmate (DEDTC) was
injectedbeforeeachstimulus,durationofbehavioralseizures
and electrical discharges were decreased [59].
Despite this work, most data support the idea of zinc
as an anticonvulsant. Increased susceptibility to kainate-
inducedseizureswasobservedinbothZnT3KOmicelacking
vesicular zinc [55] and in mice fed a zinc deﬁcient diet for
4w e e k s[ 60]. After kainate treatment, hippocampal extra-
cellular ﬂuid in zinc deﬁcient mice had increased levels of
glutamateanddecreasedlevelsofGABAcomparedtocontrol
animals [60]. Furthermore, in a mouse model of epilepsy,
seizure susceptibility was increased by zinc deﬁciency and
reduced by zinc supplementation [61]. Chelation studies
further support the anticonvulsant theory in that membrane
permeable and membrane impermeable zinc chelators have
little eﬀect on seizure activity in the CA3 region of the
hippocampus [62].
Since most studies suggest that zinc plays an anticonvul-
sant role in seizures, it is important to look at the possible
role of zinc supplementation as a therapeutic agent in the
treatment of seizure. The administration of zinc directly into
the dentate gyrus of the hippocampus delayed behavioral
seizures during electrical stimulation in adult Wistar rats
[63]. Intraperitoneal injections with a medium dose of zinc
(3mg/kg)andwiththeantiepilepticdrugvalproicacideither
alone or in combination reduced the severity of pilocarpine-
induced seizures. In contrast, high doses (60mg/kg) of zinc
exacerbated the severity of seizures highlighting the dose-
dependent eﬀect of zinc [64].
5. Conclusion
Neuronalionchannelsandreceptorsandzinctoxicityappear
to play a role in a number of neurological disorders and dis-
eases. Gaining access to neurons through these receptors
and channels, excess zinc leads to excitoxicity, oxidative
stress, and impairment of neuronal energy production, all of
which not only damage neurons but also lead to neuronal
death. Future work will be needed to develop strategies to
block zinc-mediated damage and prevent poor outcomes
associatedwithstroke,traumaticbraininjury,andepilepsyas
well as other neurodegenerative disorders that may respond
to therapies designed to modulate ion channels and zinc.
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